Effects of lipids and lipoproteins on thrombosis and rheology.
Atherosclerotic plaque rupture and erosions precipitate thrombus formation and may lead to an acute ischemic syndrome. Lipids and lipoproteins modulate the expression and/or function of thrombotic, fibrinolytic and rheologic factors, and thereby influence hemostasis and potential tissue damage resulting from vascular injury. Triglyceride-enriched lipoproteins are accompanied by elevations in factor VII clotting activity, plasminogen activator inhibitor (PAI-1) and viscosity of blood and plasma. Low density lipoprotein (LDL) promotes platelet activation and tissue factor expression and LDL levels correlate with levels of vitamin K dependent coagulation factors and fibrinogen. Conversely, LDL inhibits tissue factor pathway inhibitor (TFPI) which limits activation of the extrinsic coagulation pathway. High density lipoprotein (HDL) has anti-atherothrombotic properties that result from inhibition of platelet and erythrocyte aggregation, reduced blood viscosity and suppression of tissue factor activity and PAI-1 activity and antigen levels. The effects of lipids and lipoproteins on hemostasis and rheology may have important implications for the clinical sequelae following plaque disruption and erosion.
Rosenson
R S
RS
Department of Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, USA. rrosenso@rush.edu
Lowe
G D
GD
D000328:Adult; D001777:Blood Coagulation / Q000502:physiology; D001779:Blood Coagulation Factors / Q000378:metabolism; D003327:Coronary Disease / Q000209:etiology / Q000378:metabolism; D005260:Female; D005342:Fibrinolysis / Q000502:physiology; D018056:Hemorheology; D006801:Humans; D008055:Lipids / Q000502:physiology*; D008074:Lipoproteins / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D013927:Thrombosis / Q000150:complications / Q000378:metabolism*
D001779:Blood Coagulation Factors; D008055:Lipids; D008074:Lipoproteins